Skip to content

Clinical trials

Thrombocytopenia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Country / region: United States Clear all

165 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20024
20037
20042
20059
20069
20073
20088
200910
201011
20115
20128
201311
20148
20154
20163
20175
20188
20195
20206
20213
20223
20234
20243
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100
Terminated38
Recruiting10
Withdrawn7
Unknown status4
Active, not recruiting2
Not yet recruiting2
No longer available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline14
National Heart, Lung, and Blood Institute (NHLBI)14
M.D. Anderson Cancer Center9
Eisai Inc.5
Memorial Sloan Kettering Cancer Center4
National Institutes of Health Clinical Center (CC)4
Novartis Pharmaceuticals4
Pfizer4
Amgen3
Boston Children's Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia165
Anemia22
Purpura, Thrombocytopenic, Idiopathic17
Hematologic Diseases15
Neutropenia15
Anemia, Aplastic14
Autoimmune Diseases14
Myelodysplastic Syndromes11
Leukemia10
Primary Myelofibrosis10

Trials

Showing 1 to 25 of 165. Each trial links to its page on Pharma Observatory.

65 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.